Category: Therapeutic Area
Therapeutic Area market research reports by GlobalData
-
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031 Summary Schizophrenia is a chronic and debilitating mental illness, characterized by delusions, hallucinations, disorganized speech, trouble with thinking, and a lack of motivation. It is among the most disabling and economically catastroph ... Read More
-
Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Tria ... Read More
-
Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Tria ... Read More
-
Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points ... Read More
-
Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031
Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031 Summary Colorectal cancer (CRC) (ICD-10 = C18-C20), also referred as bowel cancer, is the cancer of the colon, rectum, or rectosigmoid junction. It is a type of gastrointestinal malignancy originating from either the colon or the rectum ... Read More
-
Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Uterine Leiomyoma (Uterine Fibroids) - Global Clinical Trials Review, 2022 provides a ... Read More
-
Panic Disorders Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Panic Disorders Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Panic Disorders - Global Clinical Trials Review, 2022 provides an overview of Panic Disorders Clinical tri ... Read More
-
Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Metastatic Melanoma - Global Clinical Trials Review, 2022 provides an overview of Metastatic Melanoma ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2022 provides an overview of Ewing Sarcoma Clinical trials sc ... Read More
-
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Interstitial Cystitis therapeutics. Key Highlights In 2022, there will be more than one mill ... Read More
-
Age-Related Macular Degeneration Epidemiology Analysis and Forecast, 2021-2031
Age-Related Macular Degeneration Epidemiology Analysis and Forecast, 2021-2031 Summary Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is the area of the retina responsible for central vision. AMD is the mo ... Read More
-
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031 Summary Osteoarthritis (OA) is a slowly progressive joint disease that is typically seen in middle-aged to elderly people. It is characterized by the breakdown of the cartilage, bony changes of the joints, deterioration of tendons and liga ... Read More
-
Cardiomyopathies Epidemiology Forecast, 2021-2031
Cardiomyopathies Epidemiology Forecast, 2021-2031 Summary Cardiomyopathy is a general term for a collection of diverse conditions of the heart muscle that inhibit the heart muscle’s ability to pump blood. The main forms of cardiomyopathy are dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy ... Read More
-
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Major Depressive Disorder therapeutics. Synopsis In 2022, there will be more than 18 mil ... Read More
-
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Rosacea therapeutics. Synopsis In 2022, there will be more than 47 million diagnosed prevalent cases of ro ... Read More
-
Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary What is Cardiomyopathy? Heterogenous collection of pathologies; normal heart muscle stiff, thin, or fills with su ... Read More
-
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research Summary Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes with the intention of regulating the human microbiome composition in a beneficial way that may ... Read More
-
Immuno-Oncology - Thematic Research
Immuno-Oncology - Thematic Research Summary The field of immuno-oncology (IO) is consolidating its presence in most major types of cancer Checkpoint modulation is the most valuable IO sector Within 2021-2022, the next immuno-oncology breakthrough has not happened High cost of therapy and need for pe ... Read More
-
Gastric and Gastroesophageal Junction Adenocarcinoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Gastric and Gastroesophageal Junction Adenocarcinoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 Summary Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC ... Read More
-
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Pha ... Read More
-
Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, ... Read More
-
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Clostridioides difficile Infections (Clostr ... Read More
-
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Tr ... Read More
-
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Co ... Read More
-
Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Developme ... Read More
Research Assistance
